Serca2a overexpression dose-dependently reduced NFATc protein nuclear accumulation and resistin protein expression (Fig. 5A), further supporting a role for Ca2+ in the upregulation of NFATc and resistin and suggests that restoration of diabetes-induced Serca2a dysfunction represses NFATc-driven resistin transcription. The gene discussed is NFATC1; the disease is diabetes mellitus.